Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Alain Baron
AddedFeb 13, 2024
UpdatedMay 31, 2026
Alain Baron

Alain Baron

Board Member, Elcelyx Therapeutics

CrunchbaseLinkedInThe Org

Alain Baron's Career

Elcelyx Therapeutics
Elcelyx Therapeutics

San Diego, CA, US

Board Member· Board
Escient Pharmaceuticals
Escient Pharmaceuticals

San Diego, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Alain Baron's Career

Elcelyx Therapeutics
Elcelyx Therapeutics
Series E$96.8M92010San Diego, CA, US
Board Member· Board

Leadership at Elcelyx Therapeutics

Brook ByersBrook ByersBoard Member
Ginger GrahamGinger GrahamBoard Member
Bosun HauBosun HauBoard Member
Jim GlasheenJim GlasheenBoard Member
Escient Pharmaceuticals
Escient Pharmaceuticals
Public$237.5M562018San Diego, CA, US
Co-Founder

Leadership at Escient Pharmaceuticals

Jason P. HaflerJason P. HaflerBoard Member
Joshua GrassJoshua GrassBoard Member
Kathleen Sereda GlaubKathleen Sereda GlaubBoard Member
Marcus BoehmMarcus BoehmCo-Founder
Kevin RaidyKevin RaidyBoard Member
Guy ServantGuy ServantBoard Member

Similar to Escient Pharmaceuticals

ScientureScientureHauppauge, NY, USDrug Development, Pharmaceuticalsest. 2019ScientureHauppauge, NY, US · est. 2019

Scienture: Advancing novel drug research and development to address unmet medical needs.

Series A · $6M5
PleoPharmaPleoPharmaPhoenixville, PA, USPharmaceuticalsest. 2020PleoPharmaPhoenixville, PA, US · est. 2020

PleoPharma: A high-ethics pharmaceutical firm dedicated to addressing significant medical needs.

Series A · $11.1M30
Inception SciencesInception SciencesSan Diego, CA, USPharmaceuticalsest. 2011Inception SciencesSan Diego, CA, US · est. 2011

Inception Sciences: Developing and marketing high-value pharmaceutical therapies for chronic diseases in the US.

Series A · $20M30
Concours PharmaceuticalsConcours PharmaceuticalsTrenton, NJ, USPharmaceuticalsest. 2018Concours PharmaceuticalsTrenton, NJ, US · est. 2018

Concours Pharmaceuticals: Innovating oral drug delivery for advanced pharmaceutical development.

Seed · $2.7M30

Alain Baron's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Alain Baron

Lonnie MoulderLonnie MoulderFounder · Tellus BioVenturesJuan EnriquezJuan EnriquezFounder & CEO · BiotechonomyRonald GoldRonald GoldBoard Member · NJ BioWilliam P WiesmannWilliam P WiesmannBoard Member · SynspiraRichard WarrenRichard WarrenCo-Founder · Elixir Bio-TechKhalid BarazanjiKhalid BarazanjiCo-Founder · Actibiomotion